These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Irreversible neurologic complications of metrizamide myelography.
    Author: Meador K, Hamilton WJ, El Gammal TA, Demetropoulos KC, Nichols FT.
    Journal: Neurology; 1984 Jun; 34(6):817-21. PubMed ID: 6539448.
    Abstract:
    Metrizamide, a major contrast agent for myelographic procedures, has rarely been reported to cause irreversible neurologic complications. The major transient neurologic alterations include neuropsychological reactions, generalized tonic-clonic seizures, and headaches. Two cases of irreversible spinal neurologic deficits resulting from metrizamide myelography are reported, and the factors that may increase the risks of complications in metrizamide myelographic studies are discussed, including preexisting dehydration, patient positioning, and the concentration of contrast agent.
    [Abstract] [Full Text] [Related] [New Search]